Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms

NCT03601611 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor
Colitis
Arthritis

Interventions

DRUG: Tocilizumab (RoACTEMRA®)

Sponsor

Herlev Hospital

Collaborators

[object Object]